TP53 and cancer: These findings concur with the results of previous studies demonstrating that SHK can inhibit proliferation of two cancer cell lines [42, 43] and activate p53 activity in various cancer cells [32] and may shed light on employment of this chemical to clinical therapy for such malignant diseases in the future.